2BB score and signals
Dianthus Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 52 | Moderate |
| Momentum | 69 | Improving |
| Financial strength | 21 | Weak |
| Quality | 73 | Strong |
| Risk | 38 | Low |
Company facts
| Founded | 2019 |
| Employees | 92 |
| 52-week range | $32.28 – $117.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -1.0819 | — | $348,840.00 |
| 2026-11-05 | — | -0.9858 | — | $433,500.00 |
| 2026-08-06 | — | -0.8748 | — | $263,751.00 |
| 2026-05-05 | -0.85 | -1.0936 | $463,000.00 | $361,294.00 |
Related companies
